IBD	Inflammatory bowel diseases
CD	Crohn’s disease
UC	Ulcerative colitis
STRIDE	Selecting Therapeutic Targets in Inflammatory Bowel Disease
FC	Fecal calprotectin
T2T	Treat-to-target
RHI	Robarts histopathology index
NHI	Nancy histopathology index
GS	Geboes score
ECCO	European Crohn’s Colitis Organisation
GHAS	Global Histological Activity Score
FDA	Food and Drug Administration’s
EMA	European Medicines Agency
MES	Mayo endoscopic subscore
RCT	Randomized controlled trial
VERDICT	actiVE ulcerative colitis, a RanDomIsed Controlled Trial
CSF	Corticosteroid free
ASUC	Acute severe ulcerative colitis